跳至主要内容
临床试验/EUCTR2013-002563-25-NL
EUCTR2013-002563-25-NL进行中(未招募)1 期

Pilot study to determine the effect of fractionated radiotherapy on expression of pro-angiogenic factors in oeshophagus carcinoma - Angiogenic factor expression during fractionated irradiation

VU University Medical Centre0 个研究点目标入组 50 人开始时间: 2013年9月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • (1) Patients that will receive standard chemoradiation treatment before surgery for oesophageal adenocarcinoma
  • (2) Ability to give informed consent
  • (3) Age 18 years or older
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 25
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 25

排除标准

  • (1) Evidence of bleeding diathesis, coagulopathy, prolonged INR or PTT
  • (2) Pregnancy
  • (3) Inflammation of the gastro-intestinal tract
  • (4) Brain metastasis
  • (5) Diastolic/ systolic Hypertension (>90/>140 mmHg), not responding to treatment
  • (6) Arterial thromboembolism in medical history
  • (7) Surgery within the month prior to start of bevacizumab treatment

研究者

发起方
VU University Medical Centre

相似试验